HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of "Buy" from Analysts

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) has earned a consensus rating of "Buy" from the eleven ratings firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $118.55.

HQY has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. JMP Securities raised their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Royal Bank Of Canada raised their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. Barrington Research raised their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th.

HealthEquity Stock Down 2.6%

HQY traded down $2.53 during midday trading on Thursday, hitting $94.38. 671,589 shares of the company's stock traded hands, compared to its average volume of 866,064. HealthEquity has a one year low of $65.01 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The stock's fifty day simple moving average is $101.65 and its 200-day simple moving average is $98.47. The company has a market cap of $8.16 billion, a PE ratio of 68.89, a price-to-earnings-growth ratio of 1.50 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter last year, the company posted $0.80 earnings per share. As a group, equities analysts anticipate that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president directly owned 75,689 shares in the company, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds have recently made changes to their positions in HQY. Farther Finance Advisors LLC increased its holdings in HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company's stock worth $26,000 after purchasing an additional 172 shares in the last quarter. Versant Capital Management Inc bought a new stake in HealthEquity in the first quarter worth approximately $28,000. WPG Advisers LLC bought a new stake in HealthEquity in the first quarter worth approximately $28,000. Transce3nd LLC bought a new stake in HealthEquity in the fourth quarter worth approximately $29,000. Finally, Proficio Capital Partners LLC bought a new stake in HealthEquity in the fourth quarter worth approximately $39,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.